217 related articles for article (PubMed ID: 22025918)
1. Fungal glucosylceramides: from structural components to biologically active targets of new antimicrobials.
Nimrichter L; Rodrigues ML
Front Microbiol; 2011; 2():212. PubMed ID: 22025918
[TBL] [Abstract][Full Text] [Related]
2. Structural diversity and biological significance of glycosphingolipids in pathogenic and opportunistic fungi.
Guimarães LL; Toledo MS; Ferreira FA; Straus AH; Takahashi HK
Front Cell Infect Microbiol; 2014; 4():138. PubMed ID: 25309884
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of the Aspergillus nidulans glucosylceramide pathway reveals that LCB Δ8-desaturation and C9-methylation are relevant to filamentous growth, lipid raft localization and Psd1 defensin activity.
Fernandes CM; de Castro PA; Singh A; Fonseca FL; Pereira MD; Vila TV; Atella GC; Rozental S; Savoldi M; Del Poeta M; Goldman GH; Kurtenbach E
Mol Microbiol; 2016 Nov; 102(3):488-505. PubMed ID: 27479571
[TBL] [Abstract][Full Text] [Related]
4. Glucosylceramide Plays a Role in Fungal Germination, Lipid Raft Organization and Biofilm Adhesion of the Pathogenic Fungus
Rochetti VP; Rollin-Pinheiro R; de Oliveira EB; Xisto MIDDS; Barreto-Bergter E
J Fungi (Basel); 2020 Dec; 6(4):. PubMed ID: 33302332
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages.
Nimrichter L; Barreto-Bergter E; Mendonça-Filho RR; Kneipp LF; Mazzi MT; Salve P; Farias SE; Wait R; Alviano CS; Rodrigues ML
Microbes Infect; 2004 Jun; 6(7):657-65. PubMed ID: 15158773
[TBL] [Abstract][Full Text] [Related]
6. Changes in glucosylceramide structure affect virulence and membrane biophysical properties of Cryptococcus neoformans.
Raj S; Nazemidashtarjandi S; Kim J; Joffe L; Zhang X; Singh A; Mor V; Desmarini D; Djordjevic J; Raleigh DP; Rodrigues ML; London E; Del Poeta M; Farnoud AM
Biochim Biophys Acta Biomembr; 2017 Nov; 1859(11):2224-2233. PubMed ID: 28865794
[TBL] [Abstract][Full Text] [Related]
7. ATP-binding cassette transporters mediate differential biosynthesis of glycosphingolipid species.
Budani M; Auray-Blais C; Lingwood C
J Lipid Res; 2021; 62():100128. PubMed ID: 34597626
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of a novel photoactivatable glucosylceramide cross-linker.
Budani M; Mylvaganam M; Binnington B; Lingwood C
J Lipid Res; 2016 Sep; 57(9):1728-36. PubMed ID: 27412675
[TBL] [Abstract][Full Text] [Related]
9. Membrane Sphingolipids Regulate the Fitness and Antifungal Protein Susceptibility of
Huber A; Oemer G; Malanovic N; Lohner K; Kovács L; Salvenmoser W; Zschocke J; Keller MA; Marx F
Front Microbiol; 2019; 10():605. PubMed ID: 31031714
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane transporter expression regulated by the glucosylceramide pathway in Cryptococcus neoformans.
Singh A; Rella A; Schwacke J; Vacchi-Suzzi C; Luberto C; Del Poeta M
BMC Res Notes; 2015 Nov; 8():681. PubMed ID: 26572681
[TBL] [Abstract][Full Text] [Related]
11. Structural analysis of glucosylceramides (GlcCer) from species of the Pseudallescheria/Scedosporium complex.
Calixto RO; Rollin-Pinheiro R; da Silva MI; Liporagi-Lopes LC; Vieira JM; Sassaki GL; Barreto-Bergter E
Fungal Biol; 2016 Feb; 120(2):166-72. PubMed ID: 26781373
[TBL] [Abstract][Full Text] [Related]
12. Structural Differences Influence Biological Properties of Glucosylceramides from Clinical and Environmental Isolates of
Caneppa A; de Meirelles JV; Rollin-Pinheiro R; Dutra Xisto MIDS; Liporagi-Lopes LC; Souza L; Villela Romanos MT; Barreto-Bergter E
J Fungi (Basel); 2019 Jul; 5(3):. PubMed ID: 31311197
[No Abstract] [Full Text] [Related]
13. Quality control of fungus-specific glucosylceramide in Cryptococcus neoformans by endoglycoceramidase-related protein 1 (EGCrP1).
Ishibashi Y; Ikeda K; Sakaguchi K; Okino N; Taguchi R; Ito M
J Biol Chem; 2012 Jan; 287(1):368-381. PubMed ID: 22072709
[TBL] [Abstract][Full Text] [Related]
14. Glucosylceramides From
Xisto MIDDS; Henao JEM; Dias LDS; Santos GMP; Calixto ROR; Bernardino MC; Taborda CP; Barreto-Bergter E
Front Microbiol; 2019; 10():554. PubMed ID: 30967849
[No Abstract] [Full Text] [Related]
15. Reconstitution of glucosylceramide flip-flop across endoplasmic reticulum: implications for mechanism of glycosphingolipid biosynthesis.
Chalat M; Menon I; Turan Z; Menon AK
J Biol Chem; 2012 May; 287(19):15523-32. PubMed ID: 22427661
[TBL] [Abstract][Full Text] [Related]
16. Psd1 binding affinity toward fungal membrane components as assessed by SPR: The role of glucosylceramide in fungal recognition and entry.
de Medeiros LN; Domitrovic T; de Andrade PC; Faria J; Bergter EB; Weissmüller G; Kurtenbach E
Biopolymers; 2014 Nov; 102(6):456-64. PubMed ID: 25283273
[TBL] [Abstract][Full Text] [Related]
17. Glucosylceramide in bunyavirus particles is essential for virus binding to host cells.
Uckeley ZM; Duboeuf M; Gu Y; Erny A; Mazelier M; Lüchtenborg C; Winter SL; Schad P; Mathieu C; Koch J; Boulant S; Chlanda P; Maisse C; Brügger B; Lozach PY
Cell Mol Life Sci; 2024 Feb; 81(1):71. PubMed ID: 38300320
[TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of anti-glucosylceramide rabbit antisera.
Brade L; Vielhaber G; Heinz E; Brade H
Glycobiology; 2000 Jun; 10(6):629-36. PubMed ID: 10814705
[TBL] [Abstract][Full Text] [Related]
19. Analysis of neutral glycosphingolipids from Trypanosoma brucei.
Uemura A; Watarai S; Kushi Y; Kasama T; Ohnishi Y; Kodama H
Vet Parasitol; 2006 Sep; 140(3-4):264-72. PubMed ID: 16806714
[TBL] [Abstract][Full Text] [Related]
20. Glucosylceramide accumulates preferentially in lamellar bodies in differentiated keratinocytes.
Hamanaka S; Nakazawa S; Yamanaka M; Uchida Y; Otsuka F
Br J Dermatol; 2005 Mar; 152(3):426-34. PubMed ID: 15787810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
